| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: CABG |
| Security Type |
Common Stock |
| Lead Underwriter |
Ladenburg Thalmann & Co Feltl & Co |
| Days In Registration |
138 |
| Date Filed |
22-Jul-2004 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture coronary artery bypass grafts |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
15.82M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
5.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
5.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
825.0K |
| File Amount |
$30.25M |
| File Price Range |
$6.00 - $5.00 |
| File Mid Price |
$5.50 |
Current Filing Information
(Amended 8-Nov-2004) |
|
US |
|
Shares Filed |
5.5M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
5.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$30.25M |
| · % Change from Original |
0.0 |
| File Price Range |
$6.00 - $5.00 |
| File Mid Price |
$5.50 |
|
